LLY
Eli Lilly and Company$864.41-3.85 (-0.44%)Prev Close$868.27·MCap$869.14B·P/E38.01·Vol1.14M·Yield0.01%
▲
Buys (12M)
6
$3.40M
▼
Sells (12M)
20
$361.99M
◆
Net Activity
Net Seller
$358.59M
●
Active Insiders
21
last 12 mo
Over the past 12 months, insider activity at Eli Lilly and Company (LLY) has been dominated by selling, with 6 insider purchases totaling $3.40M and 20 insider sales totaling $361.99M. The most recent insider transaction was by Brown Adrienne S (EVP, President LLY Imm), who sold $176.8K worth of shares on Feb 18, 2026. Eli Lilly and Company operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $869.14B.
LLY Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Brown Adrienne S | EVP, President LLY Imm | Sell | 170 | $1039.79 | $176.8K | 0 |
| Feb 16, 2026 | Custer Kenneth L. | EVP & President, Card Met Hlth | Sell | 91 | $1043.55 | $95.0K | 0 |
| Feb 16, 2026 | Montarce Lucas | EVP & CFO | Sell | 160 | $1038.26 | $166.1K | 0 |
| Feb 16, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 82 | $1034.33 | $84.8K | 0 |
| Feb 3, 2026 | Dozier Eric | EVP, Chief People Officer | Sell | 1,273 | $1037.14 | $1.32M | 0 |
| Feb 3, 2026 | Hakim Anat | EVP, GC & Secretary | Sell | 2,953 | $1037.29 | $3.06M | 0 |
| Feb 3, 2026 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,591 | $1037.44 | $1.65M | 0 |
| Feb 3, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | Sell | 1,752 | $1037.19 | $1.82M | 0 |
| Feb 3, 2026 | Rau Diogo | EVP & CIDO | Sell | 1,674 | $1036.86 | $1.74M | 0 |
| Feb 3, 2026 | Ricks David A | President, Chair, and CEO | Sell | 14,297 | $1037.12 | $14.83M | 0 |
| Feb 3, 2026 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Sell | 5,641 | $1037.20 | $5.85M | 0 |
| Feb 3, 2026 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Sell | 1,909 | $1037.35 | $1.98M | 0 |
| Feb 3, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,512 | $1037.40 | $1.57M | 0 |
| Jan 8, 2026 | LILLY ENDOWMENT INC | 10 percent owner | Sell | 292,148 | $1103.48 | $322.38M | 92,188,232 |
| Jan 6, 2026 | LILLY ENDOWMENT INC | 10 percent owner | Sell | 1,390 | $1085.01 | $1.51M | 92,189,128 |
| Nov 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $1010.50 | $1.01M | 0 |
| Aug 15, 2025 | Montarce Lucas | EVP & CFO | Buy | 715 | $691.79 | $494.6K | 0 |
| Aug 14, 2025 | Alvarez Ralph | Director | Buy | 758 | $660.25 | $500.5K | 0 |
| Aug 13, 2025 | Van Naarden Jacob | EVP & Pres., Lilly Oncology | Buy | 1,000 | $647.36 | $647.4K | 0 |
| Aug 12, 2025 | Ricks David A | President, Chair, and CEO | Buy | 1,632 | $644.77 | $1.05M | 0 |
| Aug 12, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Buy | 1,000 | $634.41 | $634.4K | 0 |
| Aug 12, 2025 | Sulzberger Gabrielle | Director | Buy | 117 | $641.18 | $75.0K | 0 |
| Aug 12, 2025 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,250 | $627.01 | $783.8K | 0 |
| Aug 4, 2025 | Seymour Melissa | EVP, Global Quality | Sell | 427 | $739.93 | $316.0K | 0 |
| May 27, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $716.41 | $716.4K | 0 |
| May 15, 2025 | Yuffa Ilya | EVP & President, LLY Int'l | Sell | 1,250 | $749.24 | $936.5K | 0 |
| Mar 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $818.24 | $818.2K | 0 |
| Mar 3, 2025 | Dozier Eric | EVP, Chief People Officer | Sell | 1,066 | $920.81 | $981.6K | 0 |
| Feb 4, 2025 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,282 | $810.82 | $1.04M | 0 |
| Feb 4, 2025 | Rau Diogo | EVP & CIDO | Sell | 1,466 | $811.24 | $1.19M | 0 |
| Feb 4, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Sell | 4,004 | $811.01 | $3.25M | 0 |
| Feb 4, 2025 | White Anne E. | EVP & Pres, Lilly Neuroscience | Sell | 1,457 | $811.14 | $1.18M | 0 |
| Sep 4, 2024 | LILLY ENDOWMENT INC | Sell | 24,084 | $966.69 | $23.28M | 96,899,880 | |
| Aug 28, 2024 | LILLY ENDOWMENT INC | Sell | 24,552 | $968.46 | $23.78M | 96,933,232 | |
| Aug 26, 2024 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 750 | $950.00 | $712.5K | 6,380 |
| Aug 23, 2024 | LILLY ENDOWMENT INC | Sell | 3,196 | $966.33 | $3.09M | 96,940,816 | |
| Jul 11, 2024 | LILLY ENDOWMENT INC | Sell | 210,000 | $939.82 | $197.36M | 97,128,744 | |
| Jul 9, 2024 | LILLY ENDOWMENT INC | Sell | 93,593 | $918.64 | $85.98M | 97,238,160 | |
| Jul 8, 2024 | LILLY ENDOWMENT INC | Sell | 52,369 | $915.18 | $47.93M | 97,249,232 | |
| Jul 3, 2024 | LILLY ENDOWMENT INC | Sell | 8,848 | $915.31 | $8.10M | 97,300,576 | |
| Jul 2, 2024 | LILLY ENDOWMENT INC | Sell | 58,749 | $915.26 | $53.77M | 97,313,424 | |
| Jul 1, 2024 | LILLY ENDOWMENT INC | Sell | 1,441 | $915.02 | $1.32M | 97,367,368 | |
| Jun 26, 2024 | LILLY ENDOWMENT INC | Sell | 188,100 | $903.82 | $170.01M | 97,499,344 | |
| Jun 25, 2024 | LILLY ENDOWMENT INC | Sell | 17,229 | $902.38 | $15.55M | 97,558,112 | |
| Jun 21, 2024 | LILLY ENDOWMENT INC | Sell | 9,671 | $902.67 | $8.73M | 97,577,256 | |
| Jun 18, 2024 | LILLY ENDOWMENT INC | Sell | 194,978 | $885.91 | $172.73M | 97,742,072 | |
| Jun 17, 2024 | LILLY ENDOWMENT INC | Sell | 15,022 | $882.47 | $13.26M | 97,781,448 | |
| Jun 11, 2024 | LILLY ENDOWMENT INC | Sell | 75,510 | $860.78 | $65.00M | 97,867,024 | |
| Jun 10, 2024 | LILLY ENDOWMENT INC | Sell | 139,490 | $852.29 | $118.89M | 97,935,936 | |
| Jun 7, 2024 | LILLY ENDOWMENT INC | Sell | 179,617 | $837.82 | $150.49M | 98,087,648 |
Showing 1–50 of 209
1 / 5
LLY Insider Buying Activity
The following table shows recent insider purchases of Eli Lilly and Company (LLY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Montarce Lucas | EVP & CFO | Buy | 715 | $691.79 | $494.6K | 0 |
| Aug 14, 2025 | Alvarez Ralph | Director | Buy | 758 | $660.25 | $500.5K | 0 |
| Aug 13, 2025 | Van Naarden Jacob | EVP & Pres., Lilly Oncology | Buy | 1,000 | $647.36 | $647.4K | 0 |
| Aug 12, 2025 | Ricks David A | President, Chair, and CEO | Buy | 1,632 | $644.77 | $1.05M | 0 |
| Aug 12, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Buy | 1,000 | $634.41 | $634.4K | 0 |
| Aug 12, 2025 | Sulzberger Gabrielle | Director | Buy | 117 | $641.18 | $75.0K | 0 |
LLY Insider Selling Activity
The following table shows recent insider sales of Eli Lilly and Company (LLY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Brown Adrienne S | EVP, President LLY Imm | Sell | 170 | $1039.79 | $176.8K | 0 |
| Feb 16, 2026 | Custer Kenneth L. | EVP & President, Card Met Hlth | Sell | 91 | $1043.55 | $95.0K | 0 |
| Feb 16, 2026 | Montarce Lucas | EVP & CFO | Sell | 160 | $1038.26 | $166.1K | 0 |
| Feb 16, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 82 | $1034.33 | $84.8K | 0 |
| Feb 3, 2026 | Dozier Eric | EVP, Chief People Officer | Sell | 1,273 | $1037.14 | $1.32M | 0 |
| Feb 3, 2026 | Hakim Anat | EVP, GC & Secretary | Sell | 2,953 | $1037.29 | $3.06M | 0 |
| Feb 3, 2026 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,591 | $1037.44 | $1.65M | 0 |
| Feb 3, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | Sell | 1,752 | $1037.19 | $1.82M | 0 |
| Feb 3, 2026 | Rau Diogo | EVP & CIDO | Sell | 1,674 | $1036.86 | $1.74M | 0 |
| Feb 3, 2026 | Ricks David A | President, Chair, and CEO | Sell | 14,297 | $1037.12 | $14.83M | 0 |
| Feb 3, 2026 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Sell | 5,641 | $1037.20 | $5.85M | 0 |
| Feb 3, 2026 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Sell | 1,909 | $1037.35 | $1.98M | 0 |
| Feb 3, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,512 | $1037.40 | $1.57M | 0 |
| Jan 8, 2026 | LILLY ENDOWMENT INC | 10 percent owner | Sell | 292,148 | $1103.48 | $322.38M | 92,188,232 |
| Jan 6, 2026 | LILLY ENDOWMENT INC | 10 percent owner | Sell | 1,390 | $1085.01 | $1.51M | 92,189,128 |
| Nov 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $1010.50 | $1.01M | 0 |
| Aug 12, 2025 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 1,250 | $627.01 | $783.8K | 0 |
| Aug 4, 2025 | Seymour Melissa | EVP, Global Quality | Sell | 427 | $739.93 | $316.0K | 0 |
| May 27, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $716.41 | $716.4K | 0 |
| May 15, 2025 | Yuffa Ilya | EVP & President, LLY Int'l | Sell | 1,250 | $749.24 | $936.5K | 0 |
| Mar 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $818.24 | $818.2K | 0 |
| Mar 3, 2025 | Dozier Eric | EVP, Chief People Officer | Sell | 1,066 | $920.81 | $981.6K | 0 |
| Feb 4, 2025 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sell | 1,282 | $810.82 | $1.04M | 0 |
| Feb 4, 2025 | Rau Diogo | EVP & CIDO | Sell | 1,466 | $811.24 | $1.19M | 0 |
| Feb 4, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Sell | 4,004 | $811.01 | $3.25M | 0 |
| Feb 4, 2025 | White Anne E. | EVP & Pres, Lilly Neuroscience | Sell | 1,457 | $811.14 | $1.18M | 0 |
| Sep 4, 2024 | LILLY ENDOWMENT INC | Sell | 24,084 | $966.69 | $23.28M | 96,899,880 | |
| Aug 28, 2024 | LILLY ENDOWMENT INC | Sell | 24,552 | $968.46 | $23.78M | 96,933,232 | |
| Aug 26, 2024 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 750 | $950.00 | $712.5K | 6,380 |
| Aug 23, 2024 | LILLY ENDOWMENT INC | Sell | 3,196 | $966.33 | $3.09M | 96,940,816 | |
| Jul 11, 2024 | LILLY ENDOWMENT INC | Sell | 210,000 | $939.82 | $197.36M | 97,128,744 | |
| Jul 9, 2024 | LILLY ENDOWMENT INC | Sell | 93,593 | $918.64 | $85.98M | 97,238,160 | |
| Jul 8, 2024 | LILLY ENDOWMENT INC | Sell | 52,369 | $915.18 | $47.93M | 97,249,232 | |
| Jul 3, 2024 | LILLY ENDOWMENT INC | Sell | 8,848 | $915.31 | $8.10M | 97,300,576 | |
| Jul 2, 2024 | LILLY ENDOWMENT INC | Sell | 58,749 | $915.26 | $53.77M | 97,313,424 | |
| Jul 1, 2024 | LILLY ENDOWMENT INC | Sell | 1,441 | $915.02 | $1.32M | 97,367,368 | |
| Jun 26, 2024 | LILLY ENDOWMENT INC | Sell | 188,100 | $903.82 | $170.01M | 97,499,344 | |
| Jun 25, 2024 | LILLY ENDOWMENT INC | Sell | 17,229 | $902.38 | $15.55M | 97,558,112 | |
| Jun 21, 2024 | LILLY ENDOWMENT INC | Sell | 9,671 | $902.67 | $8.73M | 97,577,256 | |
| Jun 18, 2024 | LILLY ENDOWMENT INC | Sell | 194,978 | $885.91 | $172.73M | 97,742,072 | |
| Jun 17, 2024 | LILLY ENDOWMENT INC | Sell | 15,022 | $882.47 | $13.26M | 97,781,448 | |
| Jun 11, 2024 | LILLY ENDOWMENT INC | Sell | 75,510 | $860.78 | $65.00M | 97,867,024 | |
| Jun 10, 2024 | LILLY ENDOWMENT INC | Sell | 139,490 | $852.29 | $118.89M | 97,935,936 | |
| Jun 7, 2024 | LILLY ENDOWMENT INC | Sell | 179,617 | $837.82 | $150.49M | 98,087,648 |
LLY Insiders
Similar Stocks to LLY
JNJ
Johnson & Johnson
$227.08+0.74%
$555.94B
ABBV
AbbVie Inc.
$196.56-0.44%
$360.31B
MRK
Merck & Co., Inc.
$110.50+0.25%
$289.58B
AMGN
Amgen Inc.
$340.40+0.04%
$188.76B
GILD
Gilead Sciences, Inc.
$128.66+0.73%
$168.65B
PFE
Pfizer Inc.
$26.61-0.65%
$156.54B
BMY
Bristol-Myers Squibb Company
$57.98+0.37%
$120.73B
BIIB
Biogen Inc.
$183.00+1.28%
$26.91B